Juno Therapeutics
Sana Biotechnology is set to start trading on Thursday.
The secretive Seattle-based biotech had raised $705.5 million since it was founded in July 2018.
We dug through its 271-page filing to unearth five key details on the Sana s financials, strategy, and future.
After raising more than $700 million since its 2018 launch, one of the biotech industry s most valuable private companies is set to start trading on Thursday.
Seattle-based Sana Biotechnology filed paperwork on January 14 for an initial public offering. Following a red-hot year for biotech IPOs in 2020, Sana is hoping to take advantage of investor enthusiasm to fuel its ambitious cell and gene therapy programs.